Akamai Technologies
American content delivery network and cloud service company
Akamai Technologies, Inc. is an American content delivery network (CDN), cybersecurity, and cloud service company, providing web and Internet security services. Akamai's intelligent edge platform is one of the world's largest distributed computing platforms, responsible for serving between 15% and 30% of all web traffic.
History[edit | edit source]
Akamai Technologies was founded in 1998 by Daniel M. Lewin and Tom Leighton, along with Preetish Nijhawan, Jonathan Seelig, and Randall Kaplan. The company was established to commercialize the research conducted by Leighton and Lewin at the Massachusetts Institute of Technology (MIT) on algorithms for efficiently delivering content over the Internet.
Services[edit | edit source]
Akamai provides a range of services designed to improve the speed, reliability, and security of Internet applications. These services include:
- Content Delivery Network (CDN): Akamai's CDN services help deliver content quickly and efficiently by caching it on servers located close to end-users.
- Web and Mobile Performance: Solutions to optimize the performance of websites and mobile applications.
- Cloud Security: Services to protect websites and applications from cyber attacks, including DDoS protection and web application firewalls.
- Enterprise Access: Secure access solutions for remote and mobile workforces.
Technology[edit | edit source]
Akamai's platform is built on a distributed network of servers, known as the "Akamai Intelligent Edge Platform." This network is designed to deliver content and applications quickly and securely by caching data at the "edge" of the Internet, closer to users.
Headquarters[edit | edit source]
Akamai's headquarters is located in Cambridge, Massachusetts. The company has offices and data centers around the world to support its global operations.
Operations[edit | edit source]
Akamai operates a network of over 240,000 servers in more than 130 countries. This extensive infrastructure allows Akamai to deliver content and services with high availability and low latency.
Gallery[edit | edit source]
Diagram of Akamai's content delivery process
Related pages[edit | edit source]
Akamai Technologies Logo
Akamai's Headquarters in Cambridge, Massachusetts
Akamai Technologies
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
